Pain Management Devices Market (By Product Type: Electrical Stimulation Devices, Radiofrequency (RF) Ablation Devices, Neuromodulation Devices, Infusion Pumps; By Application: Musculoskeletal, Brain, Cancer, Neuropathy, and Others; By End User: Physiotherapy Centers, Hospitals and Clinics, and Others) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Pain Management Devices market size was estimated at USD 6.51 billion in 2021 and is expected to surpass around USD 14.58 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 9.14% during the forecast period 2022 to 2030.

Increasing prevalence of chronic pain and technological advancements are driving the market growth. The rising prevalence of chronic diseases, coupled with the increasing geriatric population, across the globe is another major factor augmenting the market growth. A high preference for pain management devices over oral drugs and surgical interventions is also likely to be a key growth-driving factor for the market over the forecast period. The global market is expected to witness strong growth as a result of various technological advancements in this field.

The recent electrostimulation devices that are launching in the marketplace have advancements in the form of Microelectromechanical Systems (MEMS), Artificial Intelligence (AI), and machine learning applications. In September 2020, Boston Scientific launched WaveWriter Alpha Spinal Cord Stimulator Systems for personalized pain relief, in Europe. This would significantly expand the company’s portfolio. In February 2022, Boston Scientific Corp. closed the acquisition of Baylis Medical Company, Inc. This acquisition expanded Boston Scientific’s structural heart and electrophysiology product portfolios and included the radiofrequency NRG and VersaCross Transseptal Platforms and dilators used to support left heart access.

Moreover, cases of musculoskeletal disorders, such as arthritis, osteoarthritis, orthopedic degenerative disorders, and rheumatoid arthritis, are increasing at a significant rate. This has augmented the prevalence of chronic pain in these individuals and the inability to carry out routine tasks. For instance, according to the CDC, over 24.5% of adults in the U.S. were suffering from arthritis in 2020, making this the primary reason for work disability. Most of the elective surgeries were postponed or canceled during the COVID-19 pandemic to a rise in the exposure of the patients as well as the healthcare providers, which is expected to increase the demand for pain management devices. In August 2020, the U.S. FDA issued an Emergency Use Authorization (EUA) for the non-invasive vagus nerve stimulator to assist COVID-19 patients at home with asthma-related dyspnea.

Report Scope of the Pain Management Devices Market

 Drivers: Growing number of surgical procedures performed

Over the years, there has been a significant rise in the number of surgical procedures performed across the globe. This can be attributed to the rising geriatric population and the growing prevalence of obesity and other lifestyle diseases. Obesity is one of the key causes of cardiovascular and orthopedic diseases. Analgesia/pain management is the key application area of infusion pumps. Infusion pumps are also widely used for the local administration of narcotic analgesics and anesthetics following bariatric surgery, cardiothoracic surgery, and laparoscopic cholecystectomy.

PCA pumps are used to manage post-operative pain in various orthopedic surgeries such as spine surgeries and in major joint and foot/lower extremity surgical procedures. According to the National Spinal Cord Injury Statistical Center (NSCISC) 2016 datasheet, the annual incidence of spinal cord injuries (SCI) is approximately 54 cases per million population in the US or approximately 17,000 new SCI cases each year. According to the NCBI, more than 51 million inpatient surgical procedures are performed annually in the US alone, and approximately 90% of all hospitalized patients receive medications through IV. With an increase in the number of surgeries performed, the demand for infusion therapy is expected to increase.
Restraints: Product recalls

Pain management devices are used to administer critical fluids, neurostimulations and ablation that involves including high-risk medications. Errors in using these systems can cause serious harm to patients and may even lead to death. According to the Institute of Medicine (US), approximately 1.5 million patients annually experience medication errors costing USD 8,750 per Potential Adverse Drug Event (PADE).

In the past five years, the Emergency Care Research Institute (ECRI) has been pointing out errors in drug administration involving the use of infusion pumps in its Top 10 list of health technology hazards. The recall of these products due to safety and efficacy failures is a key concern for device manufacturers as it affects the sales of pain management devices. These recall activities require manufacturers to replace erroneous device with updated models and compel them to pay for serious injuries in mishaps. Hence, product recalls affect the growth of the overall pain management devices market.

Opportunities: High growth in emerging markets

Emerging economies such as China, India, and Brazil offer significant growth opportunities for players in the pain management devices market. This can primarily be attributed to the diversified healthcare markets in this region, the growing incidence of chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. In addition, infrastructural developments in healthcare facilities, increasing healthcare expenditures, and the low-cost manufacturing advantage offered by emerging countries in the Asia Pacific are expected to encourage market players to invest in this region in the coming years.

Challenges: Use of pain medications as the first line of treatment for pain management

Medication is often the first therapy that doctors use to manage chronic pain. Pain specialists prefer to prescribe medications over devices to patients suffering from pain majorly due to their easy availably, presence of substantial clinical evidence, and lower cost. Usually, physicians opt for pain management devices such as TENS or SCS only if medication and other alternative treatments do not work.

Product Insights

On the basis of products, the market has been segmented into electrical stimulators, Radiofrequency Ablation (RFA), analgesic infusion pumps, and neurostimulation. The neurostimulation segment accounted for the largest share of more than 57.5% in 2021. The growth can be attributed to the increase in the prevalence of neurological disorders. These neurostimulators play a crucial role in treating chronic pain, Parkinson’s disease, epilepsy, movement disorders, and depression. In addition, certain factors like the introduction of technologically advanced products, rising product demand, and the growing geriatric population are anticipated to drive the market. For example, according to the U.K. government, the number of people within the age group of 60-64 years increased from 3,673 thousand in 2018 to 3,974 thousand in 2021.

Similarly, the population within the age group of 70-74 years increased from 3,252 in 2018 to 3,390 in 2021. Thus, the increasing geriatric population is likely to fuel the market growth this demographic is at a greater risk of chronic illness. The RFA segment is expected to register the fastest CAGR over the forecast period owing to its wide application scope in pain management, surgical oncology, gynecology, cardiology & cardiac rhythm management, and cosmetology. Radiofrequency ablation treatment is more beneficial in treating patients with multiple tumors than treating the patients via open surgery, thus fueling the segment growth. For instance, in June 2020, Boston Scientific launched a tool to monitor the effect of radiofrequency energy delivery during cardiac ablation procedures called DIRECTSENSE.

Application Insights

On basis of application, the market is segmented into cancer, neuropathic pain, facial & migraine, musculoskeletal disorder, trauma, and others. The neuropathic pain segment dominated the market with a revenue share of more than 31.5% in 2021. The growth can be attributed to the growing prevalence of the target population and increasing initiatives by the industry players. According to the U.S. Centers for Disease Control and Prevention, in 2019, 65% of Americans aged 65 years or above suffered from chronic pain. In addition, neuropathic pain affects 3% to 17% of adults. The aforementioned factors are expected to propel the segment growth.

The cancer segment is expected to register the fastest CAGR over the forecast period. The rising cancer cases have led to an increase in the product demand to reduce the pain caused by nerve compression mainly because of the tumor compressing and other variables depending upon cancer’s progression. Moreover, the growing prevalence of genetic diseases, such as Acute Lymphoblastic Leukemia (ALL), is also expected to drive market growth during the forecast period. According to a report published by the National Cancer Institute, an estimated 5,690 new cases of ALL and an estimated 1,580 deaths were recorded in 2021.

End User Insights

Based on the end user, the physiotherapy centers dominate the pain management devices market during the forecast period. The pain management devices are highly used in physiotherapy centers. The rehabilitation, health promotion, and injury prevention are all aspects of physiotherapy. The treatment requires high quality of pain management devices.

On the other hand, the hospitals and clinics is expected to grow at rapid pace during the forecast period. The pain management devices are used in the hospitals and clinics on a large scale. The cancer patients need regular checkups. The cancer specialists use pain management devices tremendously for the treatment of various kind of cancers.

Regional Insights

North America accounted for the largest revenue share of more than 46.10% in 2021 owing to the favorable healthcare infrastructure, which facilitates easy access to advanced pain management devices. Moreover, increasing government initiatives, such as the Precision Medicine and Affordable Care Act, along with a well-planned reimbursement scenario in this region is contributing to the market growth. The regional market is also driven by the presence of well-established healthcare facilities, a growing aging population, and a high incidence of hypertension & stroke. With an increase in the elderly population, the market is expected to show a higher growth rate, as the aging population is at greater risk of chronic illness.

According to an NCBI publication, the prevalence of cerebral aneurysms in 2020 is approximately 3.2%, with a mean age of 50 years and an overall 1:1 gender ratio. Furthermore, the presence of key players in this region is also expected to drive market growth. These players include Baxter International Inc., Boston Scientific Corp., Medtronic, Abbott, Stryker Corp., and others. These players are involved in many strategic initiatives for growth in the market. For instance, in May 2019, Abbott partnered with the U.S. National Institutes of Health (NIH) for the development of unique insights and driving applications of various neuromodulation therapies.

The market in Asia Pacific is anticipated to grow at the fastest car during the forecast period. This growth can be attributed to R&D investments to produce technologically advanced healthcare treatment options. Moreover, the presence of several trade agreements is increasing the chances for market growth in the region. For instance, the Asia Pacific Trade Agreement (APTA) between China, Bangladesh, India, Lao PDR, Republic of Korea, Mongolia, and Sri Lanka has promoted trade liberalization and widened import and export opportunities amongst participating nations.

Some of the prominent players in the Pain Management Devices Market include:

• Nevro Corporation
• LivaNova
• SPR Therapeutics
• Boston Scientific Corporation
• Abbott
• DJO Global LLC
• Medtronic
• Omron Healthcare Inc.
• Smiths Medical
• Melsungen AG

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Pain Management Devices market

By Product Type

• Electrical Stimulation Devices
• TENS
• Others
• Radiofrequency (RF) Ablation Devices
• Neuromodulation Devices
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Neurostimulators
• Others
• Infusion Pumps
• Intrathecal Infusion Pumps
• External Infusion Pumps

By Application

• Musculoskeletal
• Brain
• Cancer
• Neuropathy
• Others

By End User

• Physiotherapy Centers
• Hospitals and Clinics
• Others

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Pain Management Devices industry analysis from 2022 to 2030 to identify the prevailing Pain Management Devices industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Pain Management Devices industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Pain Management Devices industry trends, key players, market segments, application areas, and market growth strategies.